Accueil
Détail de l'auteur
Auteur P. VICKERMAN |
Documents disponibles écrits par cet auteur (33)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
L. PLATT ; P. EASTERBROOK ; E. GOWER ; B. MCDONALD ; K. SABIN ; C. McGOWAN ; I. YANNY ; H. RAZAVI ; P. VICKERMAN |Background: At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV-HCV co-infection. We sought to characterise the epidemiology an[...]Article : Périodique
L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN |HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]Article : Périodique
J. CSETE ; A. KAMARULZAMAN ; M. KAZATCHKINE ; F. ALTICE ; M. BALICKI ; J. BUXTON ; J. CEPEDA ; M. COMFORT ; E. GOOSBY ; J. GOULAO ; C. HART ; T. KERR ; A. M. LAJOUS ; S. LEWIS ; N. MARTIN ; D. MEJIA ; A. CAMACHO ; D. MATHIESON ; I. OBOT ; A. OGUNROMBI ; S. SHERMAN ; J. STONE ; N. VALLATH ; P. VICKERMAN ; T. ZABRANSKY ; C. BEYRER |ENGLISH: In September, 2015, the member states of the UN endorsed Sustainable Development Goals (SDGs) for 2030, which aspire to human-rights-centred approaches to ensuring the health and wellbeing of all people. The SDGs embody both the UN Cha[...]Article : Périodique
H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN |Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]Article : Périodique
R. CORNISH ; J. MACLEOD ; J. STRANG ; P. VICKERMAN ; M. HICKMAN |Objective To investigate the effect of opiate substitution treatment at the beginning and end of treatment and according to duration of treatment. Design Prospective cohort study. Setting UK General Practice Research Database Participants Pri[...]Article : Périodique
H. FRASER ; J. ZIBBELL ; T. HOERGER ; S. HARIRI ; C. VELLOZZI ; N. K. MARTIN ; A. H. KRAL ; M. HICKMAN ; J. W. WARD ; P. VICKERMAN |Background and aims: Effective strategies are needed to address dramatic increases in hepatitis C virus (HCV) infection among people who inject drugs (PWID) in rural settings of the United States. We determined the required scale-up of HCV treat[...]Périodique
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus
KUMARANAYAKE L. ; P. VICKERMAN ; D. WALKER ; SAMOSHKIN S. ; ROMANTZOV V. ; EMELYANOVA Z. ; ZVIAGIN V. ; C. WATTS | 2004ENGLISH : Aim. To undertake a cost-effectiveness analysis of a harm reduction and HIV prevention project for injecting drug users (IDUs) in Eastern Europe. Economic evaluation methods were adapted to consider the effect of an 8-month financing[...]Article : Périodique
M. HICKMAN ; C. STEER ; K. TILLING ; A. G. LIM ; J. MARSDEN ; T. MILLAR ; J. STRANG ; M. TELFER ; P. VICKERMAN ; J. MACLEOD |AIMS: To estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is associated with a greater reduction in the risk of all-cause mortality (ACM) and opioid drug-related poisoning (DRP) mortality. DESIGN: Cohort stud[...]Article : Périodique
K. M. E. TURNER ; S. HUTCHINSON ; P. VICKERMAN ; V. HOPE ; N. CRAINE ; N. E. PALMATEER ; M. MAY ; A. TAYLOR ; D. DE ANGELIS ; S. CAMERON ; J. PARRY ; M. LYONS ; D. GOLDBERG ; E. ALLEN ; M. HICKMAN |AIMS To investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs). DESIGN Meta-analysis and pooled analysis, with logistic re[...]Article : Périodique
S. COLLEDGE ; A. PEACOCK ; J. LEUNG ; S. LARNEY ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT |Background: People who inject drugs (PWID) are at an elevated risk of fatal overdose in the first year after experiencing a non-fatal event. Such non-fatal events may also result in overdose-related sequelae, ranging from physical injury to para[...]Article : Périodique
I. GOUNTAS ; V. SYPSA ; O. ANAGNOSTOU ; N. MARTIN ; P. VICKERMAN ; E. KAFETZOPOULOS ; A. HATZAKIS |Aims: To project the impact of scaling-up oral anti-viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who inject drugs (PWID) in Greece, to estimate the relationship between required treatment le[...]NouveautéArticle : Périodique
L. WIESSING ; E. KALAMARA ; J. STONE ; P. ALTAN ; L. VAN BAELEN ; A. FOTIOU ; D. GARCIA ; J. GOULAO ; B. GUARITA ; V. HOPE ; M. JAUFFRET-ROUSTIDE ; L. JURGELAITIENE ; M. KABERG ; A. KAMARULZAMAN ; L. LEMSALU ; A. KIVITE-URTANE ; B. KOLARIC ; L. MONTANARI ; M. ROSINSKA ; L. SAVA ; I. HORVATH ; T. SEYLER ; V. SYPSA ; A. TARJAN ; I. YIASEMI ; R. ZIMMERMANN ; M. FERRI ; K. DOLAN ; A. UUSKULA ; P. VICKERMAN |Background: People who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes. Aim: We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infe[...]Article : Périodique
A. TRICKEY ; M. T. MAY ; V. HOPE ; Z. WARD ; M. DESAI ; E. HEINSBROEK ; M. HICKMAN ; P. VICKERMAN |Introduction: Syringes with attached needles (low dead space syringes [LDSS]) retain far less blood following injection than syringes with detachable needles (high dead space syringes [HDSS]). People who inject drugs (PWID) who share needles/syr[...]